Inhibiting BACH1 sensitizes triple-negative breast cancer to metformin

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer

Patient sample, cell culture and mouse studies suggest BACH1 inhibitors could sensitize triple-negative breast

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE